时间:2026-11-20 09:46:00 来源:网络整理编辑:時尚
On the morning of March 20, eye surgeon Jason Comander injected viruses carrying lab-grown genes int
On the morning of March 20, eye surgeon Jason Comander injected viruses carrying lab-grown genes into the eyes of a boy whose vision had been gradually disappearing.
If all goes as planned, the 13-year-old patient -- who lives with an inherited genetic defect that causes blindness -- will experience an improvement in eyesight in about a month.
After a series of tests, the U.S. Food and Drug Administration (FDA) approved this gene-therapy treatment, called Luxturna, in December 2017.
SEE ALSO:Doctors find virus in a pond, use it to destroy antibiotic-resistant bacteria in man's heartThree months later, the procedure Comander performed at Massachusetts Eye and Ear served as the first time an FDA-approved gene therapy was used on a person living with an inherited, and incurable, genetic disease. There are no other effective treatments for this specific retinal disease.

"It's a huge step in the right direction," said Comander, associate director of the Inherited Retinal Disorders Service at the Boston-based hospital, in an interview.
"Most of the patients are legally blind by their 20s or 30s," said Comander. "Suffice to say, these are really terrible diseases."
Dr. Jason Comander performing the FDA-approved gene-therapy procedure.Credit: Mass. eye and earScientists have been working on this novel type of treatment for decades, including as part of FDA trial programs. Comander notes the treatment affects different patients in different ways. Sometimes the vision improvement is dramatic. One previous patient, from an earlier FDA trial, no longer needed to attend a specialized school for children with blindness, Comander said.
"This has been a dream of the field for 30 years, and there have been sobering setbacks," said Tim Cherry, who researches inherited blindness and other visual disorders at Seattle Children’s Research Institute, in an interview. Cherry disclosed he has collaborated with Comander on research before, but played no part in the development of this treatment.
"It can improve people's lives in a way that might have been considered science fiction years ago," said Cherry. It should be noted, however, that while blind people face challenges due to inaccessibility, many live happy, fulfilled lives.
The rare, mutated gene in afflicted patients, known as RPE65, prevents the retina, a light-sensitive tissue behind the eye, from working correctly. Specifically, the gene prevents retinal cells from properly producing proteins, resulting in deteriorating eyesight. Many patients become legally blind, and some lose all their eyesight.
Diagram of the eye.Credit: Wikimedia Commons/Medical gallery of Blausen Medical 2014.This novel gene therapy, called gene-replacement therapy, is designed to replace the mutated genes with genes that work, and accordingly, improve a patient's eyesight. Synthetic genes are first grown in a lab and then inserted into viruses commonly found in the human eye. The viruses -- whose mission is to invade eye cells and infuse genetic material into them -- are then carefully placed in the patient's retina.
These viruses, said Cherry, naturally live in our eyes and are harmless.
Because there were no other meaningful treatments available for this incurable disease, the FDA approved the treatments more rapidly than it typically does, under programs called Breakthrough Therapy and Priority Review.
These sorts of accelerated approvals require drug companies and clinicians to continue monitoring the treatments after their initial FDA approval, to ensure they're truly safe and effective enough for consumers to use. The safety warnings on the Luxturna website underscore these potential hazards, including potential eye infections and further declines in vision.
Earlier in 2017, the FDA had approved two other gene-therapy treatments for cancers, which aren't considered genetically-inherited diseases. The FDA now plans for gene therapies to play a more prominent role in combating previously untreatable diseases.
"I believe gene therapy will become a mainstay in treating, and maybe curing, many of our most devastating and intractable illnesses,” FDA Commissioner Scott Gottlieb said when announcing the approval of Luxturna.
Although gene therapies provide treatments for historically unmanageable diseases, they can be markedly more expensive than conventional treatments, especially if the disease -- such as this retinal mutation -- is rare.
The price right now is prohibitively high for most Americans: It costs $425,000, per eye. The pharmaceutical company that produces the treatment, Spark Therapeutics, notes on its website that it assists by directly contacting insurers and offers payment plans.
But Cherry hopes this gene therapy can be expanded to other similar diseases, driving down the cost of artificially producing the genes.
"We’re all in it to try and improve people's lives. So making the treatment more accessible is on everyone’s mind," said Cherry.
TopicsHealth
This chart shows just how high Simone Biles can jump2026-11-20 09:39
巴黎VS蘭斯首發 :姆巴佩攜迪馬利亞出戰 梅西替補2026-11-20 09:21
李霄鵬國足名單仍是熟麵孔 老將打天下是殘酷現狀2026-11-20 09:20
皇馬VS埃爾切首發:本澤馬維尼修斯出戰 阿紮爾登場2026-11-20 09:15
'Rocket League' Championship Series Season 2 offers $250,000 prize pool2026-11-20 08:57
火力全開 !拜仁20輪狂轟65球 刷新德甲同期進球紀錄2026-11-20 08:39
絕平 !皇馬各項賽事五連勝遭終結 聯賽四分領跑2026-11-20 08:22
曼聯前瞻 :爭四關鍵戰役事關6分 C羅受傷出戰成疑2026-11-20 08:05
MashReads Podcast: What makes a good summer read?2026-11-20 08:03
還賣嗎?巴薩爭議先生一劍封喉 哈維妙手把他激活2026-11-20 07:35
Ivanka Trump's unpaid interns share cringeworthy financial advice2026-11-20 09:40
熱議洛國富滯留機場發飆 :裝大爺裝習慣了 不發錢放飛自我了2026-11-20 09:32
呂迪格遭開瓶器+打火機砸 圖赫爾:盡快製止這種事2026-11-20 09:18
水慶霞 :比賽越打越好 張睿和王霜一樣重要2026-11-20 09:02
Dramatic photo captures nun texting friends after Italy earthquake2026-11-20 08:01
賴斯神發言 !輸給曼聯後笑稱 我最喜歡老特拉福德2026-11-20 07:35
火力全開!拜仁20輪狂轟65球 刷新德甲同期進球紀錄2026-11-20 07:34
王霜:還是希望出國深造 自己在前100球員中能有一席之地2026-11-20 07:33
Balloon fanatic Tim Kaine is also, of course, very good at harmonica2026-11-20 07:09
巴薩前瞻:紅藍軍團現體能危機 登貝萊將再遭封殺2026-11-20 07:02